Ibrance, also known by its generic name palbociclib, is a medication used in the treatment of certain types of breast cancer. It belongs to a class of drugs called CDK 4/6 inhibitors, which work by blocking proteins that promote the growth of cancer cells.
Ibrance is typically prescribed in combination with other medications, such as hormone therapy, to treat hormone receptor-positive, HER2-negative advanced breast cancer. It is often used in postmenopausal women, but can also be used in premenopausal women in certain cases.
As with any medication, Ibrance may cause side effects. Common side effects include fatigue, nausea, diarrhea, and decreased appetite. It can also cause a decrease in certain blood cell counts, which may increase the risk of infection or bleeding. It is important to discuss any side effects with your healthcare provider, as they may be able to provide recommendations to help manage them.
It is important to take Ibrance exactly as prescribed by your healthcare provider. Missing doses or taking the medication at different times than recommended can affect its effectiveness. Your healthcare provider may also recommend regular blood tests to monitor your response to the medication and check for any potential side effects.
If you have been prescribed Ibrance, it is important to have open and honest communication with your healthcare provider about your treatment plan and any concerns you may have. They are there to support you and help you navigate your treatment journey.
EN 
ES 
FR 
PT 
ZH